A PROGNOSTIC IMMUNOTHERAPY MODEL FOR 4T1 BREAST CANCER WITH COMBINED CYCLOPHOSPHAMIDE AND TLR AGONIST (Q5120283)
From MaRDI portal
scientific article; zbMATH DE number 7245664
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A PROGNOSTIC IMMUNOTHERAPY MODEL FOR 4T1 BREAST CANCER WITH COMBINED CYCLOPHOSPHAMIDE AND TLR AGONIST |
scientific article; zbMATH DE number 7245664 |
Statements
A PROGNOSTIC IMMUNOTHERAPY MODEL FOR 4T1 BREAST CANCER WITH COMBINED CYCLOPHOSPHAMIDE AND TLR AGONIST (English)
0 references
9 September 2020
0 references
breast cancer
0 references
immunotherapy
0 references
TLR agonists
0 references
MDSCs
0 references
0 references
0 references
